期刊文献+

携带HSV-1TK基因的逆转录病毒载体构建及在HeLa细胞中的表达 被引量:1

Construction of recombinant retroviral vector carrying herpes simplex virus thymidine kinase-1 gene and identification of its expression in HeLa cells
原文传递
导出
摘要 目的:构建携带单纯疱疹病毒脱氧胸腺嘧啶激酶基因(herpes simplex virus thymidine kinase,HSV-TK)的逆转录病毒,用于宫颈癌的治疗研究。方法:用限制性内切酶从质粒pcDNA3.1/HA-myc-His(-)Z-TK切下HSV-1TK cDNA序列,亚克隆入逆转录病毒载体pLXSN得到重组质粒pLXSN-TK,鉴定正确的阳性重组质粒经PA317细胞包装,G418筛选,在NIH3T3细胞进行病毒滴度测定。然后用病毒感染人宫颈癌细胞HeLa。PCR、RT-PCR和Western blotting方法检测HSV-1TK基因在HeLa中的整合和表达情况。结果:重组质粒pLXSN-TK经PA317细胞包装后收获病毒上清,感染HeLa细胞,检测发现HSV-1TK基因整合到细胞基因组DNA中,并且能有效的转录和翻译。结论:成功构建了逆转录病毒pLXSN-TK,该病毒能有效感染HeLa细胞,并使携带的治疗基因HSV-1TK在细胞中表达,为今后HSV-1TK基因治疗宫颈癌的研究奠定基础。 Objective:To construct the recombinant retrovirus carrying herpes simplex virus thymidine kinase-1(HSV-1TK) gene and to observe the expression of HSV-1TK in cervical carcinoma cell line HeLa. Methods:The HSV-1TK cDNA was digested by restriction endonuclease from plasmid pcDNA3.1/HA-myc-His(-) Z-TK and then directionally inserted into retroviral vector pLXSN to construct recombinant plasmid pLXSN-TK. The pLXSN-TK was transferred into retroviral producer cell line PA317 for packaging retrovirus and then the resultant retrovirus was applied to infected the HeLa cells. The integration of HSV-1TK gene into the HeLa cells genome was assayed by PCR. The expression of HSV-1TK gene was detected by RT-PCR and Western blot. Results:The HSV-1TK gene was integrated into the genome of HeLa cells shown by results of PCR after retroviral infection. The expression of HSV-1TK gene was confirmed by RT-PCR and Western blotting. Conclusion:The recombinant retrovirus carrying HSV-1TK gene was constructed successfully and may be a potentially effective strategy for the treatment of cervical cancer.
出处 《现代生物医学进展》 CAS 2010年第2期205-207,共3页 Progress in Modern Biomedicine
基金 教育部中国博士后科学基金(20080440778) 深港创新圈计划(08fz-11)
关键词 单纯疱疹病毒脱氧胸腺嘧啶激酶基因 逆转录病毒 宫颈癌 HSV-1TK Retrovirus Cervical cancer
  • 相关文献

参考文献8

  • 1Li N, Zhou J, Weng D,et al. Adjuvant adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of liver transplantation in patients with advanced hepatocellular carcinoma[J]. Clin Cancer Res, 2007,13(19):5847-5854.
  • 2King GD, Kroeger KM, Bresee CJ,et al. Flt3L in combination with HSV-1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits[J]. Mol Ther, 2008,16(4):682-690.
  • 3Freytag SO, Stricker H, Pegg J,et al. Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer[J]. Cancer Res, 2003,63(21):7497-7506.
  • 4Sung MW, Yeh HC, Thung SN, et al. Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial [J]. Mol Ther, 2001,4(3): 182-191.
  • 5Zhang J, Wang Z, Wei F, et a;. Computational modeling and functional analysis of Herpes simplex virus type-1 thymidine kinase and Escherichia coli cytosine deaminase fusion protein[J]. Biochem Biophys Res Commun, 2007, 360(1):46-50.
  • 6Rainov NG. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme[J]. Hum Gene Ther, 2000,11 (17):2389-2401.
  • 7Huang G, Song Y, Xiao L, et al. The bystander effect of HSV-tk/GCV system on human cervical carcinoma cell line ME180[J]. Sichuan Da Xue Xue Bao Yi Xue Ban, 2003,34(1):51-54.
  • 8Chuah MK, Collen D, Vandendriessche T. Preclinical and clinical gene therapy for haemophilia. Haemophilia [J]. 2004, Suppl 4: 119-125.

同被引文献11

  • 1樊德厚,王永利.中国药物大全(西药卷)[M].北京:人民卫生出版社,2005.610.
  • 2Arnaud F,Varelaa M,Speneer T E,et al. Coevolution of endogenous betaretroviruses of sheep and their host[J]. Cellular and Molecular Life Sciences, 2008,65 : 3422 - 3432.
  • 3Cote M, Zheng Y M, Liu S L. Receptor binding and low pH co activate oncogenic retrovirus envelope-mediated fusion. Journal of Virology, 2009,83(22) : 11447--11455.
  • 4Dunlap K A,Palmarini M, Adelson D L, et al. Sheep endogenous betaretroviruses (enJSRVs) and the hyaluronidase 2 (HYAL2) receptor in the ovine uterus and eoneeptus[J]. Biology of Repro duetion, 2005, 73(2) :271-279.
  • 5Guillomot M. Cellular interactions duing implantationin domestic ruminants[J]. J Reprod Fertil Suppl, 1995,49 : 39-51.
  • 6Johnson C, Sanders K, Hung F. Jaagsiekte sheep retrovirus transformation in Madin-Darby canine kidney epithelial cell threedimensional culture [J]. Journal of Virology, 2010, 84 ( 10 ) : 5379-5390.
  • 7Liu S L, Miller D A. Transformation of Madin-Darby canine kid- ney epithelial cells by sheep retrovirus envelope proteins [J]. Journal of Virology, 2005, 79(2):927-933.
  • 8Miller A D. Hyaluronidase 2 and its intriguing role as a cell-entry receptor for oncogenie sheep retroviruse[J]. Semin Cancer Biol, 2008, 18(4): 296-301.
  • 9Miller A D. Identification of Hyal2 as the cell-surface receptor for Jaagsiekte sheep retrovirus and ovine nasal adenocarcinoma virus[J]. Curt Top Microbiol Immunol, 2003, 275 : 179-199.
  • 10Rai S K, Dub F M, Vigdorovich V, et al. Candidate tumor suppressor Hyal2 is a glycosylphosphatidylinositol (GPI)-anehored cell-surface receptor for Jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation[J]. Proc Natl Acad Sci, 2001, 98:4443-4448.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部